NIAID Locks In Data Science Training Grant Decisions
Published Date: 4/3/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a closed meeting on April 28, 2025, to review special grant applications focused on training in data science for infectious and immune diseases. This meeting affects researchers applying for these grants and helps decide who gets funding to boost important scientific training. The meeting is private to protect sensitive information and will be held via video.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Closed Review of T32 Data-Science Grants
On April 28, 2025, from 10:00 a.m. to 5:00 p.m., a closed National Institute of Allergy and Infectious Diseases meeting will review and evaluate Competitive Revision Supplement applications to existing T32 institutional research training programs to include data science for infectious and immune mediated diseases. The meeting is closed under 5 U.S.C. 552b(c)(4) and (c)(6) to protect confidential trade secrets, patentable material, and personal information, and will be held as a video-assisted meeting at 5601 Fishers Lane, Rockville, MD.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13612 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important health research grant applications. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants and the public can expect no changes in funding timing or amounts, just careful, confidential reviews.
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
2026-13244 — The Federal Demonstration Partnership; Phase VIII Notice
The Federal Demonstration Partnership (FDP) is inviting colleges, universities, research groups, and hospitals that get federal research money to join its Phase VIII starting in 2027. This phase will keep testing new ways to make research funding and rules easier and faster. Applications are due by September 15, 2026, with the program running through the end of 2032.
Previous / Next Documents
Previous: 2025-05727 — National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
The National Institute of Allergy and Infectious Diseases is holding a closed video meeting on May 1, 2025, to review important grant applications for clinical trials. This meeting affects researchers seeking funding and keeps sensitive info private. It helps decide who gets money to fight infectious diseases and supports exciting new medical research.
Next: 2025-05729 — Agency Information Collection Extension
The Department of Energy is extending a form they collect info with for three more years. This means businesses and people who fill out this form get to keep doing it without new changes or extra costs. The extension helps keep things running smoothly and on time!